New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - montelukast sodium 4.15mg equivalent to montelukast 4 mg - chewable tablet - 4 mg - active: montelukast sodium 4.15mg equivalent to montelukast 4 mg excipient: aspartame cherry flavour 501027 ap0551 colloidal silicon dioxide croscarmellose sodium stear-o-wet m mannitol microcrystalline cellulose - indicated in paediatric patients 2 to 5 years of age for the relief of daytime and night-time symptoms of seasonal allergic rhinitis and perennial allergic rhinitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - montelukast sodium 5.19mg equivalent to montelukast 5 mg - chewable tablet - 5 mg - active: montelukast sodium 5.19mg equivalent to montelukast 5 mg excipient: aspartame cherry flavour 501027 ap0551 colloidal silicon dioxide croscarmellose sodium stear-o-wet m mannitol microcrystalline cellulose - indicated in paediatric patients 6 to 14 years of age for the relief of daytime and night-time symptoms of seasonal allergic rhinitis and perennial allergic rhinitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - montelukast sodium 10.4mg equivalent to montelukast 10 mg - film coated tablet - 10 mg - active: montelukast sodium 10.4mg equivalent to montelukast 10 mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate mannitol microcrystalline cellulose opadry blue y-22-10538 opadry clear ys-1-7006 sodium laurilsulfate - indicated in adults 15 years of age and older for the relief of day-time and night-time symptoms of seasonal allergic rhinitis and perennial allergic rhinitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - tenofovir disoproxil maleate 300mg equivalent to tenofovir disoproxil 245mg - film coated tablet - 300 mg - active: tenofovir disoproxil maleate 300mg equivalent to tenofovir disoproxil 245mg excipient: colloidal silicon dioxide hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 32k505018 - tenofovir disoproxil mylan is indicated for the treatment of chronic hepatitis b in adults and paediatric patients 12 years of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg excipient: crospovidone microcrystalline cellulose opadry brown 15b565009 purified water stearic acid - for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. for the prevention of cmv disease in solid organ transplant patients at risk.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg excipient: mannitol sodium citrate water for injection - · treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density. · prevention of postmenopausal osteoporosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer, eudragit s 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate   methacrylic acid copolymer microcrystalline cellulose purified talc purified water   starch sucrose titanium dioxide triethyl citrate - short term relief of constipation

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol tartrate 5mg - solution for injection - 5 mg/5ml - active: metoprolol tartrate 5mg excipient: sodium chloride water for injection - disturbances of cardiac rhythm, including supraventricular and ventricular arrhythmias.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - abacavir sulfate 702.78mg equivalent to abacavir 600 mg;  ; lamivudine 300mg - film coated tablet - active: abacavir sulfate 702.78mg equivalent to abacavir 600 mg   lamivudine 300mg excipient: colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white 13b58894 purified talc silicified microcrystalline cellulose - antiretroviral combination therapy for the treatment of hiv in adults and adolescents from 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous);   - film coated tablet - 0.5 mg - active: entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous)   excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1r-7003 purified water - entecavir is indicated for the treatment of chronic hbv infection in adults with evidence of active liver inflammation.